Team

Adi Zamir

                              

Adi Zamir is the aMoon-Roche Partnership Leader at StarFinder Lab.


She has over 20 years experience in senior positions in global and local companies specializing in technology integration and services.
For the past 7 years, she has led startups in the digital health field, and was highly engaged in the development of AI/ML and Apps.
Adi has vast knowledge and experience in various industry verticals (Finance, Government, Health etc.), focused on developing technology as an accelerator of business performance and innovation, while building and leading winning teams and achieving finance and business goals in dynamic and disruptive environments.
Adi holds a B.Ed in Science Education, an M.A. in Education from Hebrew University of Jerusalem and an M.A. in Law and EMBA, from Bar Ilan University.

Roy Wiesner

                                             

Roy Wiesner is a partner at aMoon Fund, Israel’s largest life sciences and healthtech VC.


He focuses on early-stage investments, primarily in digital health, diagnostics and medical devices. Prior to joining aMoon, he was CEO of a Cleantech incubator and seed-stage fund owned by CK Hutchison (Fortune 500 company), where he was also involved in forming a number of ventures. Roy was previously a corporate lawyer, specializing in M&A, Private Equity and VC transactions, working for international law firm Weil Gotshal in New York and Hong Kong, and as a partner for a prominent law firm in Tel Aviv. He holds an LL.B from the Hebrew University and a dual MBA from the LSE and Columbia University.

Alexandra
Vallon-Eberhard

               

Alexandra Vallon-Eberhard is a Senior Director of Global Business Development at Roche and the Operational Team Lead for Roche at StarFinder Lab.

She has over 15 years of international business development, investment, innovation, and managerial experience, with ten years of basic and applied Immunology and IVD research under her belt. Alexandra specializes in ecosystem partnerships, end-to-end disease management & prevention, diagnostics, and digital health. Known for quickly converting strategic plans into result-driven tactical and operational reality, Alexandra has guided many Israeli and Swiss start-ups in their financial, strategic, and operational growth, while also supporting over 40 of the Fortune 500 companies in their external growth strategy. She holds an International MBA from Bar Ilan University, a Ph.D. in Immunology and Virology from Claude Bernard Lyon I University, and was a postdoctoral associate at the Weizmann Institute of Science.

James Phillips-Portillo

                              

James Phillips-Portillo is a Staff User Researcher at Roche.

He has 10 years of experience in medical device R&D and is passionate about 

using user centered design to focus and accelerate early research. In his current role he coaches R&D teams in design thinking and co-creation and runs generative and evaluative user research projects to understand clinical care pain-points, validate hypothesized problems, and test solution concepts with customers. Before joining Roche he earned a BA in English Literature from Carleton College, a Ph.D. in Physiological Sciences with a focus on neuroscience from the University of Arizona, and was a postdoctoral associate at the University of Massachusetts Medical School (now known as UMass Chan Medical School).

Matthias Zach

                                             

Matthias Zach is Startup Innovation Lead at Roche Information Solutions.

He is passionate about exploring new digital tech and co-creating new digital business models with startups to address the most important challenges in healthcare.

Matthias has been working for Roche Diagnostics as well as Merck KGaA in different roles, implementing strategic innovation projects. For more than a decade, he has been actively driving collaborations within the healthcare ecosystem. He truly believes that collaboration between different players is key to advance healthcare, and especially digital health.

By training, Matthias is a pharmaceutical process engineer and holds a Master’s and PhD degree in business administration.